Abstract:Abstract Background and Aims The impact of social deprivation on the progression of Chronic Kidney Disease (CKD) to End Stage Kidney Disease (ESKD) requiring Renal Replacement Therapies (RRTs) and death has been demonstrated by large cohort studies produced both in the US and the UK. Nonetheless, there is still insufficient evidence, which might depend on the difficulty of comparing Health Care Systems from different countries, the lack of a standardized measure of social deprivation and the difficulty of obtaining follow-ups long enough to intercept all clinical outcomes. This study aims to fill this gap by analyzing a large cohort of patients affected by CKD identified in Healthcare Electronic Records through a validated algorithm. Method The study population consisted of all adult incident CKD cases treated conservatively, residents in the Lazio Region, that occurred between the 1st of January 2012 and the 31st of December 2021. The exposure was the deprivation index (DI), a composite indicator at the census block level, which integrates many aspects: low level of education, unemployment, non-home ownership, one parent family and overcrowding. The DI divided the Lazio residents in 5 classes according to the quintiles of its distribution (form very low to very high deprivation). The study outcomes were all-cause mortality and ESKD. The health status of CKD patients was characterized using the hospital discharges for hypertension, heart failure, diabetes, ischemic cardiopathy, obesity and other conditions, in the two years before the identification. Patients were followed form the incident date up to the date of death, ESKD, emigration from Lazio region or 31/12/2022, whichever came first. Cox regression analyses were performed to study the association between DI and adverse outcomes, estimating crude and adjusted Hazard Ratios (HR) and 95% Confidence Intervals (95% CI). The interaction between DI and sex was tested. Results From 2012 to 2021, there were 127 457 new CKD cases, 55.9% males. The average age was 72.2 (±13.7 SD) for males and 74.4 (±14.8 SD) for females, characteristics by deprivation index are reported in Table 1. During the follow-up, on average 4.3 years (±3.2 SD), 57 158 patients (45%) died and 5994 developed ESKD requiring RRTs (5%). The mortality analysis showed a statistically significant interaction between DI and sex. In males, there was a strong association between DI and mortality in both age-adjusted and fully-adjusted models (Fig. 1A), with a statistically significant trend across DI classes. In females, there was an association with a statistically significant trend across DI categories but the only statistically significant different HR was very high DI VS. very low DI (HR = 1.05; 95% CI = 1.00-1.09) (Fig. 1B). The association was much stronger for males then for females. In the ESKD outcome analysis there was not an interaction between sex and DI; hence, sex was used as confounder. The age-adjusted HR and the fully-adjusted HR of DI on ESKD did not show any trend across the DI categories and then the low and medium deprived had a lower ESKD risk compared to the very deprived. Conclusion The present study is so far the largest European prospective cohort regarding the association between socioeconomic position and CKD. The HR of mortality was inferior to the one found in the UK studies (HR 1.6). The most likely explanation is that we have stratified by sex and adjusted for comorbidities. In our study the most deprived patients have a higher risk of death, but not of ESKD requiring RRTs, showing socioeconomic inequalities in the worst possible outcome, that probably occurred before the progression of the disease in most deprived patients. Further studies are needed to confirm this association that can lead both individual and Public Health decisions.

Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016–2020

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis

Vascular access for hemodialysis in Italy: What a national survey reveals

Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study

#1942 Social deprivation and chronic kidney disease: a population based cohort study in Italy

Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction

Gender Disparities in Vascular Access and One-Year Mortality among Incident Hemodialysis Patients: An Epidemiological Study in Lazio Region, Italy

The diabetic patient between sustainability and effectiveness of new treatments

Epidemiological Analysis in a NorthEastern District of Italy Focusing on Access to Nephrological Care

Heart failure in the Veneto region of Italy: analysis of therapeutic pathways and the utilization of healthcare resources

Physical activity and exercise programs for kidney patients: an Italian survey of nephrology centres

Hemodialysis Versus Peritoneal Dialysis: an Observational Study in Two International Centers

Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes

The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O

Improving well-being and enhancing awareness in patients undergoing hemodialysis through the person-centered IARA model: an exploratory study

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study

Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study

Present and future of kidney replacement therapy in Italy: the perspective from Italian Dialysis and Transplantation Registry (IDTR)

Investigational new drugs for the treatment of chronic renal failure: an overview of the literature

[The highlights of dialysis in 2023]